Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic lupus erythematosus. A prospective analysis.

R Grigor, J Edmonds, R Lewkonia

    Annals of the Rheumatic Diseases
    |April 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Synovial tissue hypoxia and inflammation in vivo.

    Annals of the rheumatic diseases·2010
    Same author

    Unregulated prescribing of anti-tumour necrosis factor agents does not mean inappropriate prescribing.

    Annals of the rheumatic diseases·2009
    Same author

    Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009.

    Annals of the rheumatic diseases·2009
    Same author

    EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis.

    Annals of the rheumatic diseases·2009
    Same author

    Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database.

    Annals of the rheumatic diseases·2009
    Same author

    Comparison of interferon {gamma} release assays and conventional screening tests before tumour necrosis factor {alpha} blockade in patients with inflammatory arthritis.

    Annals of the rheumatic diseases·2009
    Same journal

    Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups.

    Annals of the rheumatic diseases·2026
    Same journal

    A data-driven, weighted flare score that accurately predicts organ damage in systemic lupus erythematosus.

    Annals of the rheumatic diseases·2026
    Same journal

    PD-1 signalling restrains pathogenic T peripheral helper and effector CD4⁺ T cell functions in rheumatoid arthritis.

    Annals of the rheumatic diseases·2026
    Same journal

    Remission of refractory lupus nephritis is temporally associated with antitumour therapy, including durvalumab for endometrial carcinoma.

    Annals of the rheumatic diseases·2026
    Same journal

    Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project.

    Annals of the rheumatic diseases·2026
    Same journal

    Commentary on 'Assessing the performance of AI chatbots in answering patients common questions about low back pain'.

    Annals of the rheumatic diseases·2026
    See all related articles

    Systemic lupus erythematosus (SLE) frequently causes widespread organ involvement, including subclinical respiratory and cerebral issues. A conservative management approach in SLE patients shows a high 5-year survival rate of 98%.

    Area of Science:

    • Rheumatology
    • Internal Medicine
    • Clinical Research

    Background:

    • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystemic inflammation.
    • Understanding the full spectrum of organ involvement in SLE is crucial for effective patient management.
    • Previous studies may not have fully captured the extent of subclinical disease activity.

    Purpose of the Study:

    • To prospectively assess the spectrum of organ involvement in a cohort of 50 SLE patients.
    • To evaluate the impact of a conservative management strategy on patient outcomes.
    • To determine the long-term survival rates associated with this approach.

    Main Methods:

    • Prospective study involving 50 patients with SLE.
    • Comprehensive clinical and laboratory assessments during elective hospital admissions.

    Related Experiment Videos

  • Mean observation period of 29 months, with follow-up based on clinical status.

    • Main Results:

    • All patients exhibited widespread multisystem involvement.
    • Subclinical respiratory and cerebral function abnormalities were common, even during clinical remission.
    • An estimated 5-year survival rate of 98% was observed.

    Conclusions:

    • SLE universally involves multiple organ systems, often with subclinical manifestations.
    • A conservative management strategy for SLE appears to be highly effective, correlating with excellent long-term survival.
    • Further research into early detection of subclinical disease is warranted.